医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Fime Accredited to Support Adoption of Digital Healthcare in India

2022年07月26日 PM12:30
このエントリーをはてなブックマークに追加


 

BENGALURU, India

Fime has been empaneled as an official certifier to support India’s digital health initiative – Ayushman Bharat Digital Mission (ABDM). Being implemented by the National Health Authority (NHA), ABDM aims to create a seamless online platform for the healthcare ecosystem, enabling data to be shared seamlessly between healthcare providers while ensuring privacy. Fime’s expertise and cloud-based open API testing tool, TrustAPI+, are helping healthcare stakeholders to ensure APIs are implemented correctly and join the ABDM ecosystem.

“We are working to create a national digital health ecosystem in an efficient, inclusive, affordable, timely and safe manner,” comments Mr. Kiran Gopal, Director, National Health Authority (NHA). “This is only possible if we can facilitate access to a wide-range of data, information and infrastructure services. Leveraging open, interoperable, standards-based digital systems will ensure the security, confidentiality and privacy of health-related personal information. Our testing partners are at the heart of realizing this vision.”

Fime’s consultants and testing experts are supporting healthcare providers including hospitals, diagnostic labs, insurance and clinical research companies to certify their API implementations. By working with Fime, stakeholders can navigate the three certification milestones:

  • Milestone 1 – compulsory for all participants to enable health ID capture and verification for seamless customer registration.
  • Milestone 2 – for entities becoming Health Information Providers (HIP) to share digital records via health apps.
  • Milestone 3 – for entities becoming Health Information Users (HIU) to view patients’ medical history, with their consent.

“With healthcare – as with financial services – data is the new currency,” adds Mr. Angaj Bhandari, India and South Asia Managing Director at Fime. “APIs have proven their value in facilitating the seamless and secure exchange of data between parties. India is taking the lead on bringing this value to healthcare. This will improve clinical decision making for healthcare providers, simplify telemedicine, ease access to treatment for patients and empower clinical research, among other benefits. Certification is a key enabler, protecting the integrity of the space, the APIs it relies on and ensuring the right parties are involved.”

As with all products launched on the Fime Test Factory platform, TrustAPI+ is accessed through a secure cloud portal, allowing multiple users to collaborate on projects even when located across different regions. Contact Fime to learn more about how its experts can support your account aggregator API and integrations projects.

– ENDS –

About Fime

Fime enables its clients to create and launch trusted and secure solutions with consulting and testing services in payments, smart mobility, biometrics, authentication and open banking. It offers global cross-industry perspective, local insight, and unique heritage in testing and certification. Fime’s consultants provide transformative business expertise, partnering with organizations worldwide to define, design, deliver and test their products and services.

With 400+ experts around the world, Fime works strategically to help its clients turn ideas into reality, swiftly take products to market, and achieve competitive advantage. Working together, Fime turns powerful innovations into the future of trusted transactions.

Making innovation possible.

www.fime.com | Blog | Twitter | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20220725005464/en/

CONTACT

For further Fime media information, please contact:

Fergus Straiton fergus@iseepr.co.uk at iseepr + 44 (0) 113 350 1922

Stéphanie Pietri stephanie.pietri@fime.com at Fime

同じカテゴリーの記事 

  • EMS Kegel Trainer BODYDOCTOR Opens New Era of Health Care Solutions in Global Femcare Market
  • EMSケーゲルトレーナー BODYDOCTOR、Femcareのグローバル市場でK-HEALTH CAREに注目が集まる
  • InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
  • METIS第3相臨床試験で主要評価項目を達成、非小細胞肺がんからの脳転移患者における頭蓋内進行までの期間を統計学的に有意に延長
  • Poxel to Report Its 2023 Annual Results by the End of April 2024